GB1377762A - Creation of Inventions and Patents with Artificial Intelligence

GB1377762A – 8-oxo-5-thia-1-azabicyclo-4,2,0 oct- 2-ene-compounds process for their manufacture and compositions containing them
– Google Patents

GB1377762A – 8-oxo-5-thia-1-azabicyclo-4,2,0 oct- 2-ene-compounds process for their manufacture and compositions containing them
– Google Patents
8-oxo-5-thia-1-azabicyclo-4,2,0 oct- 2-ene-compounds process for their manufacture and compositions containing them

Info

Publication number
GB1377762A

GB1377762A
GB4996271A
GB4996271A
GB1377762A
GB 1377762 A
GB1377762 A
GB 1377762A
GB 4996271 A
GB4996271 A
GB 4996271A
GB 4996271 A
GB4996271 A
GB 4996271A
GB 1377762 A
GB1377762 A
GB 1377762A
Authority
GB
United Kingdom
Prior art keywords
group
compounds
carboxylic
formula
groups
Prior art date
1970-10-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Application number
GB4996271A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis AG

Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1970-10-27
Filing date
1971-10-27
Publication date
1974-12-18

1970-10-27
Priority claimed from CH1584070A
external-priority
patent/CH555859A/en

1971-10-27
Application filed by Ciba Geigy AG
filed
Critical
Ciba Geigy AG

1974-12-18
Publication of GB1377762A
publication
Critical
patent/GB1377762A/en

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

C07D501/02—Preparation

C07D501/08—Preparation by forming the ring or condensed ring systems

Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE

Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

Y02P20/00—Technologies relating to chemical industry

Y02P20/50—Improvements relating to the production of bulk chemicals

Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

1377762 Substituted ceph-3-em-4-carboxylic acids CIBA-GEIGY AG 27 Oct 1971 [27 Oct 1970 4 March 1971 24 May 1971] 49962/71 Heading C2C Novel 7 – amino – ceph – 3 – em – 4 – carboxylic acid compounds of the formula wherein R 1 a represents hydrogen or an amino protective group R 1 A, R 1 b represents hydrogen or an acyl group or R 1 A and R 1 b together represent a bivalent amino protective group and R2 represents hydrogen or an organic radical R 2 A which together with the -C(=O)-O- grouping forms a protected carboxyl group and salts of such compounds containing salt forming groups, are prepared by oxidizing azetidin-2-one compounds wherein R 1 A, R 1 b and R 2 A have the above significance and each of R a , R b and R c represents an unsubstituted or substituted hydrocarbon group with an organic sulphoxide in the presence of an agent having dehydrating to oxidize the carbinol group to a formyl group followed by ring closure. Conversion to acid addition, organic amine quaternary, ammonium and metal salts may be carried out by normal methods using products containing a basic group at the 7-position or a free carboxylic group at the 4-position. In the case where a basic group is at the 7-position and a free carboxylic group is at the 4-position, an internal salt may be formed. In the above process it is possible, where necessary, to protect temporarily groups which do not participate in the reaction, e.g. OH, SH and NH 2 groups by acylation, tritylation or silylation and COOH groups by esterfication including silylation. Novel compounds of the first formula above and prepared by the above process may subsequently be modified to form other compounds within the said formula. Thus the examples describe the preparation of compounds by converting a 4- carboxylic ester group to the 4-carboxylic group, a 7#-acylamino group to the 7#-amino group, a 4-carboxylic group to a 4-carboxylic ester group. The starting materials for the above processes are prepared as disclosed in Specification 1,361,199. Pharmaceutical compositions having antibiotic activity contain the novel compounds of the first formula above and a suitable carrier and may be in a form suitable for enteral, parenteral or topical administration.

GB4996271A
1970-10-27
1971-10-27
8-oxo-5-thia-1-azabicyclo-4,2,0 oct- 2-ene-compounds process for their manufacture and compositions containing them

Expired

GB1377762A
(en)

Applications Claiming Priority (3)

Application Number
Priority Date
Filing Date
Title

CH1584070A

CH555859A
(en)

1970-10-27
1970-10-27
8-oxo-7-amino-5-thia-1-azabicyclo (4,2,0) oct-2-ene compds – prepd fr 4-beta-(2ho-ethylthio)-1-alphaphosphoranylidene-protected carboxymeth

CH319571

1971-03-04

CH754371

1971-05-24

Publications (1)

Publication Number
Publication Date

GB1377762A
true

GB1377762A
(en)

1974-12-18

Family
ID=27174185
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

GB4996271A
Expired

GB1377762A
(en)

1970-10-27
1971-10-27
8-oxo-5-thia-1-azabicyclo-4,2,0 oct- 2-ene-compounds process for their manufacture and compositions containing them

Country Status (15)

Country
Link

US
(1)

US4735937A
(en)

JP
(2)

JPS5753358B1
(en)

AR
(3)

AR192590A1
(en)

AT
(2)

AT315363B
(en)

BE
(1)

BE774480A
(en)

DD
(3)

DD95380A5
(en)

DE
(1)

DE2151567C2
(en)

ES
(1)

ES396388A1
(en)

FR
(1)

FR2111859B1
(en)

GB
(1)

GB1377762A
(en)

HU
(2)

HU166373B
(en)

IE
(1)

IE35709B1
(en)

IL
(1)

IL37879A
(en)

NL
(3)

NL7114738A
(en)

SE
(2)

SE411902B
(en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

BE793724A
(en)

1972-01-12
1973-07-05
Smith Kline French Lab

PROCESS FOR THE PREPARATION OF CEPHALOSPHORINS NOT SUBSTITUTED IN POSITION 3, NEW CEPHALOSPORINS OBTAINED AND THEIR USE

CH591500A5
(en)

1972-06-29
1977-09-30
Ciba Geigy Ag

AR206201A1
(en)

1972-06-29
1976-07-07
Ciba Geigy Ag

PROCEDURE FOR OBTAINING ACID COMPOUNDS 7BETA-AMINO-3-CEFEM-3-01-4-CARBOXILICO0-SUBSTITUIDOS

JPS62123969U
(en)

1986-01-28
1987-08-06

US20070056652A1
(en)

2005-01-05
2007-03-15
Ruppman Kurt H Sr
Method and Apparatus for Inerting Head Space of a Container by Way of Chute Attachment

WO2008157308A2
(en)

2007-06-13
2008-12-24
Wayne State University Board Of Governors
A zwitterion solution for low-volume therapeutic delivery

US20110021469A1
(en)

2007-06-13
2011-01-27
Meythaler Jay M
baclofen solution for low-volume therapeutic delivery

EP2862569A1
(en)

2011-09-09
2015-04-22
Cubist Pharmaceuticals, Inc.
Methods for treating intrapulmonary infections

US8809314B1
(en)

2012-09-07
2014-08-19
Cubist Pharmacueticals, Inc.
Cephalosporin compound

US8476425B1
(en)

2012-09-27
2013-07-02
Cubist Pharmaceuticals, Inc.
Tazobactam arginine compositions

US9872906B2
(en)

2013-03-15
2018-01-23
Merck Sharp & Dohme Corp.
Ceftolozane antibiotic compositions

PE20160048A1
(en)

2013-03-15
2016-02-12
Merck Sharp & Dohme

ANTIBIOTIC COMPOSITIONS OF CEFTOLOZANE

US20140274991A1
(en)

2013-03-15
2014-09-18
Cubist Pharmaceuticals, Inc.
Ceftolozane pharmaceutical compositions

ES2800603T3
(en)

2013-09-09
2021-01-04
Merck Sharp & Dohme

Treatment of infections with ceftolozane / tazobactam in patients with renal impairment

US20150094293A1
(en)

2013-09-27
2015-04-02
Calixa Therapeutics, Inc.
Solid forms of ceftolozane

CN110437257B
(en)

2019-08-28
2021-01-12
河北恒百药业有限公司
Preparation method of ceftizoxime intermediate 7-ANCA

Family Cites Families (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

DE1935970A1
(en)

1968-07-23
1970-01-29
Ciba Geigy

Oxyacetic acid compounds

1971

1971-10-07
IL
IL37879A
patent/IL37879A/en
unknown

1971-10-08
IE
IE1263/71A
patent/IE35709B1/en
unknown

1971-10-16
DE
DE2151567A
patent/DE2151567C2/en
not_active
Expired

1971-10-22
SE
SE7113435A
patent/SE411902B/en
unknown

1971-10-22
AT
AT917371A
patent/AT315363B/en
not_active
IP Right Cessation

1971-10-22
AT
AT917171A
patent/AT306926B/en
not_active
IP Right Cessation

1971-10-22
SE
SE7113436A
patent/SE412239B/en
unknown

1971-10-26
BE
BE774480A
patent/BE774480A/en
not_active
IP Right Cessation

1971-10-26
NL
NL7114738A
patent/NL7114738A/xx
unknown

1971-10-26
ES
ES396388A
patent/ES396388A1/en
not_active
Expired

1971-10-26
NL
NL7114739A
patent/NL7114739A/xx
active
Search and Examination

1971-10-26
HU
HUCI1177A
patent/HU166373B/hu
unknown

1971-10-26
DD
DD158555A
patent/DD95380A5/xx
unknown

1971-10-26
HU
HUCI1180A
patent/HU166549B/hu
unknown

1971-10-26
FR
FR7138371A
patent/FR2111859B1/fr
not_active
Expired

1971-10-26
DD
DD158563A
patent/DD95381A5/xx
unknown

1971-10-26
NL
NL7114740A
patent/NL7114740A/xx
not_active
Application Discontinuation

1971-10-26
DD
DD158556A
patent/DD94817A5/xx
unknown

1971-10-27
JP
JP46086174A
patent/JPS5753358B1/ja
active
Pending

1971-10-27
JP
JP8617371A
patent/JPS562076B1/ja
active
Pending

1971-10-27
AR
AR238709A
patent/AR192590A1/en
active

1971-10-27
AR
AR238707A
patent/AR193624A1/en
active

1971-10-27
GB
GB4996271A
patent/GB1377762A/en
not_active
Expired

1971-10-27
AR
AR238708A
patent/AR192589A1/en
active

1986

1986-03-28
US
US06/846,504
patent/US4735937A/en
not_active
Expired – Lifetime

Also Published As

Publication number
Publication date

HU166549B
(en)

1975-04-28

DD94817A5
(en)

1973-01-05

AT306926B
(en)

1973-04-25

AR192589A1
(en)

1973-02-28

IL37879A
(en)

1974-12-31

HU166373B
(en)

1975-03-28

JPS5753358B1
(en)

1982-11-12

AT315363B
(en)

1974-05-27

DD95381A5
(en)

1973-02-05

ES396388A1
(en)

1975-01-16

IL37879A0
(en)

1971-12-29

US4735937A
(en)

1988-04-05

DD95380A5
(en)

1973-02-05

NL7114739A
(en)

1972-05-02

BE774480A
(en)

1972-04-26

IE35709B1
(en)

1976-04-28

NL7114738A
(en)

1972-05-02

NL7114740A
(en)

1972-05-02

IE35709L
(en)

1972-04-27

SE411902B
(en)

1980-02-11

SE412239B
(en)

1980-02-25

DE2151567A1
(en)

1972-05-04

AR193624A1
(en)

1973-05-11

FR2111859A1
(en)

1972-06-09

JPS562076B1
(en)

1981-01-17

AR192590A1
(en)

1973-02-28

DE2151567C2
(en)

1982-11-04

FR2111859B1
(en)

1975-08-01

Contact information